ProCE Banner Activity

How I Have Been Managing My Patients With CLL During the COVID-19 Pandemic in NYC: Selecting Therapy to Minimize Risk

Clinical Thought
How are you managing your patients with CLL during the COVID-19 pandemic? Here, I share my experiences during the height of the pandemic in New York City and offer recommendations to minimize the risk to your patients.

Released: August 11, 2020

Expiration: August 10, 2021

No longer available for credit.

Share

Faculty

Jacqueline Barrientos

Jacqueline Barrientos, MD, MS

Associate Professor of Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Attending Physician
Division of Hematology/Oncology
Northwell Health System
Lake Success, New York

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

AstraZeneca

Faculty Disclosure

Primary Author

Jacqueline Barrientos, MD, MS

Associate Professor of Medicine
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Attending Physician
Division of Hematology/Oncology
Northwell Health System
Lake Success, New York

Jacqueline Barrientos, MD, MS, has disclosed that she has received funds for research support from Oncternal; consulting fees from AstraZeneca, Bayer, Genentech, Gilead Sciences, and Sandoz; and other financial or material support from Janssen.